See the source article by following the link below:
Science hinted that cancer patients could take less of a $148,000-a-year drug. Its maker tripled the price of a pill. Is this a problem?
Science hinted that cancer patients could take less of a $148,000-a-year drug. Its maker tripled the price of a pill. Is this a problem?
No comments:
Post a Comment